BSE filing, NSE: RPGLIFE. Summary written from the filing by ALFA Finder's alert engine.
RPG Life Sciences Ltd: key numbers
- Share price
- ₹2,844.00
- Market cap
- ₹4,704 Cr
- Revenue (annual)
- ₹707.5 Cr
- Net profit (annual)
- ₹115.2 Cr
- P/E (TTM)
- 39.3×Sector 46.1×
- Promoter holding
- 72.95%+0.00% QoQ
- FII holding
- 0.87%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from RPG Life Sciences Ltd
All →RPG Life Sciences Other Announcement
This is the quarterly shareholding pattern filing for RPG Life Sciences Ltd for the quarter ended September 30, 2026.
RPG Life Sciences Capital Structure Change
Clarus Trust acquired 37,463 shares of RPG Life Sciences through an open market transaction. This acquisition increases the acquirer's total stake to 7.04%.
RPG Life Sciences Merger & Restructuring
RPG Life Sciences announced the amalgamation of its wholly-owned subsidiary, Actis Generics, into its other subsidiary, RPG Active Pharma Limited. No share exchange is involved.
RPG Life Sciences Acquisition
RPG Life Sciences completed its acquisition of the entire stake in Actis Generics Private Limited, making it a subsidiary of the company.
RPG Life Sciences Price Movement Clarification
RPG Life Sciences clarified that the recent increase in its trading volume is attributable to market conditions and there is no undisclosed price-sensitive information.
RPG Life Sciences Merger & Restructuring
RPG Life Sciences completed the slump sale of its API and intermediates business to Raghava Life Sciences Private Limited, effective September 16, 2026.
Other board meeting date announcements
All →Dangee Dums Board Meeting Date
Dangee Dums will hold a board meeting on 2 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. Trading window closure runs until 4 November 2026.
Relic Technologies Board Meeting Date
Relic Technologies intimated a board meeting on 2 Nov 2026 to consider unaudited standalone and consolidated Q2 results for the period ended 30 Sep 2026. The trading window closes from 1 Oct 2026 until 48 hours after the results are disseminated.
EPL Board Meeting Date
EPL will hold a board meeting on November 4, 2026 to consider September quarter results. Trading window re-opens 48 hours after results are declared.
Chemplast Sanmar Board Meeting Date
Chemplast Sanmar will meet on 4 November 2026 to approve September quarter results. The trading window stays closed until 6 November 2026.
Kemistar Corporation Board Meeting Date
Kemistar Corporation scheduled a board meeting on 6 November 2026 to consider unaudited results. Trading window remains closed until 8 November 2026.
Rajasthan Cylinders & Containers Board Meeting Date
Rajasthan Cylinders & Containers intimated a board meeting on 05 November 2026 to approve unaudited results for quarter and half year ended 30 September 2026. The trading window stays closed until 07 November 2026.